MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy
Melanoma associated antigens (MAGE) are potential targets for immunotherapy and have been associated with poor overall survival (OS) in head and neck squamous cell carcinoma (HNSCC). However, little is known about MAGE in lymph node metastases (LNM) and recurrent disease (RD) of HNSCC. To assess whe...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
January 27, 2017
|
| In: |
OncoTarget
Year: 2017, Jahrgang: 8, Heft: 9, Pages: 14719-14735 |
| ISSN: | 1949-2553 |
| DOI: | 10.18632/oncotarget.14830 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.18632/oncotarget.14830 Verlag, Volltext: http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=14830&path[]=47376 
|
| Verfasserangaben: | Simon Laban, Gregor Giebel, Niklas Klümper, Andreas Schröck, Johannes Doescher, Giulio Spagnoli, Julia Thierauf, Marie-Nicole Theodoraki, Romain Remark, Sacha Gnjatic, Rosemarie Krupar, Andrew G. Sikora, Geert Litjens, Niels Grabe, Glen Kristiansen, Friedrich Bootz, Patrick J. Schuler, Cornelia Brunner, Johannes Brägelmann, Thomas K. Hoffmann, Sven Perner |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1582433461 | ||
| 003 | DE-627 | ||
| 005 | 20230427193220.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181030s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.18632/oncotarget.14830 |2 doi | |
| 035 | |a (DE-627)1582433461 | ||
| 035 | |a (DE-576)512433461 | ||
| 035 | |a (DE-599)BSZ512433461 | ||
| 035 | |a (OCoLC)1341021904 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Laban, Simon Andreas |d 1981- |e VerfasserIn |0 (DE-588)138995524 |0 (DE-627)703174983 |0 (DE-576)309849039 |4 aut | |
| 245 | 1 | 0 | |a MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy |c Simon Laban, Gregor Giebel, Niklas Klümper, Andreas Schröck, Johannes Doescher, Giulio Spagnoli, Julia Thierauf, Marie-Nicole Theodoraki, Romain Remark, Sacha Gnjatic, Rosemarie Krupar, Andrew G. Sikora, Geert Litjens, Niels Grabe, Glen Kristiansen, Friedrich Bootz, Patrick J. Schuler, Cornelia Brunner, Johannes Brägelmann, Thomas K. Hoffmann, Sven Perner |
| 264 | 1 | |c January 27, 2017 | |
| 300 | |a 17 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 30.10.2018 | ||
| 520 | |a Melanoma associated antigens (MAGE) are potential targets for immunotherapy and have been associated with poor overall survival (OS) in head and neck squamous cell carcinoma (HNSCC). However, little is known about MAGE in lymph node metastases (LNM) and recurrent disease (RD) of HNSCC. To assess whether MAGE expression increases with metastasis or recurrence, a tissue microarray (TMA) of 552 primary tumors (PT), 219 LNM and 75 RD was evaluated by immunohistochemistry for MAGE antigens using three monoclonal antibodies to multiple MAGE family members. Mean expression intensity (MEI) was obtained from triplicates of each tumor specimen. The median MEI compared between PT, LNM and RD was significantly higher in LNM and RD. In paired samples, MEI was comparable in PT to respective LNM, but significantly different from RD. Up to 25% of patients were negative for pan-MAGE or MAGE-A3/A4 in PT, but positive in RD. The prognostic impact of MAGE expression was validated in the TMA cohort and also in TCGA data (mRNA). OS was significantly lower for patients expressing pan-MAGE or MAGE-A3/A4 in both independent cohorts. MAGE expression was confirmed as a prognostic marker in HNSCC and may be important for immunotherapeutic strategies as a shared antigen. | ||
| 700 | 1 | |a Grabe, Niels |e VerfasserIn |0 (DE-588)123210615 |0 (DE-627)716920697 |0 (DE-576)364937602 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t OncoTarget |d [Erscheinungsort nicht ermittelbar] : Impact Journals LLC, 2010 |g 8(2017), 9, Seite 14719-14735 |h Online-Ressource |w (DE-627)63035975X |w (DE-600)2560162-3 |w (DE-576)325343764 |x 1949-2553 |7 nnas |a MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy |
| 773 | 1 | 8 | |g volume:8 |g year:2017 |g number:9 |g pages:14719-14735 |g extent:17 |a MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18632/oncotarget.14830 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=14830&path[]=47376 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20181030 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 123210615 |a Grabe, Niels |m 123210615:Grabe, Niels |d 700000 |d 716000 |e 700000PG123210615 |e 716000PG123210615 |k 0/700000/ |k 1/700000/716000/ |p 14 | ||
| 999 | |a KXP-PPN1582433461 |e 3030096793 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title_sort":"MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy","title":"MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy"}],"language":["eng"],"name":{"displayForm":["Simon Laban, Gregor Giebel, Niklas Klümper, Andreas Schröck, Johannes Doescher, Giulio Spagnoli, Julia Thierauf, Marie-Nicole Theodoraki, Romain Remark, Sacha Gnjatic, Rosemarie Krupar, Andrew G. Sikora, Geert Litjens, Niels Grabe, Glen Kristiansen, Friedrich Bootz, Patrick J. Schuler, Cornelia Brunner, Johannes Brägelmann, Thomas K. Hoffmann, Sven Perner"]},"note":["Gesehen am 30.10.2018"],"id":{"doi":["10.18632/oncotarget.14830"],"eki":["1582433461"]},"recId":"1582433461","relHost":[{"disp":"MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapyOncoTarget","language":["eng"],"title":[{"title_sort":"OncoTarget","title":"OncoTarget","subtitle":"open access impact journal"}],"note":["Gesehen am 16.08.2018"],"id":{"zdb":["2560162-3"],"eki":["63035975X"],"issn":["1949-2553"]},"recId":"63035975X","physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedKey":"2010","publisher":"Impact Journals LLC","dateIssuedDisp":"2010-","publisherPlace":"[Erscheinungsort nicht ermittelbar]"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.2010,Mai -"],"part":{"year":"2017","issue":"9","text":"8(2017), 9, Seite 14719-14735","extent":"17","volume":"8","pages":"14719-14735"}}],"person":[{"display":"Laban, Simon Andreas","family":"Laban","role":"aut","roleDisplay":"VerfasserIn","given":"Simon Andreas"},{"given":"Niels","roleDisplay":"VerfasserIn","role":"aut","display":"Grabe, Niels","family":"Grabe"}],"physDesc":[{"extent":"17 S."}],"origin":[{"dateIssuedDisp":"January 27, 2017","dateIssuedKey":"2017"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a LABANSIMONMAGEEXPRES2720 | ||